Published in Infect Immun on March 01, 1981
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo (1963) 3.16
Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo (1968) 2.62
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells. J Immunol (1978) 1.96
Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo. J Exp Med (1975) 1.90
Strain difference of delayed-type hypersensitivity to BCG and its genetic control in mice. Infect Immun (1978) 1.59
Effect of cyclophosphamide on delayed hypersensitivity to Staphylococcus aureus in mice. Immunology (1977) 1.36
The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens. Immunology (1975) 1.25
Correspondence: Transfer of immunity to T. cruzi. Trans R Soc Trop Med Hyg (1974) 1.03
The effects of some immunosuppressive agents in experimental chronic Chagas's disease. Trans R Soc Trop Med Hyg (1971) 0.98
Suppression of anamnestic cellular responses during experimental American trypanosomiasis. J Parasitol (1978) 0.94
Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BALB/c mice. Clin Exp Immunol (1978) 0.93
Antigens of the subcellular fractions of Trypanosoma cruzi. II. Flagellar and membrane fraction. J Protozool (1977) 0.91
The effect of BCG on the course of experimental Chagas' disease in mice. Int J Parasitol (1975) 0.91
Adoptive transfer of protection against Trypanosoma cruzi with lymphocytes and macrophages. Infect Immun (1979) 0.81
Trypanosoma cruzi: protection of mice with epimastigote antigens from immunologically different parasite strains. Exp Parasitol (1974) 0.79
Systemic immunological reactivity in the absence of delayed type hypersensitivity during murine leprosy. Cell Immunol (1978) 0.78
The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis. Immunol Lett (1998) 1.23
Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J Immunol (1999) 1.08
Antibody dependent cell-mediated cytotoxicity against Trypanosoma cruzi. Parasitology (1977) 1.05
Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp Parasitol (1990) 0.99
Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol (1999) 0.96
Presence of Trypanosoma cruzi antigen on the surface of both infected and uninfected cells in tissue culture. Parasitology (1980) 0.92
Robust gammadelta+ T cell expansion in infants immunized at birth with BCG vaccine. Vaccine (2007) 0.91
Subclinical atherosclerosis is related to injury level but not to inflammatory parameters in spinal cord injury subjects. Spinal Cord (2010) 0.91
Immature macrophages derived from mouse bone marrow produce large amounts of IL-12p40 after LPS stimulation. J Leukoc Biol (2003) 0.90
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. Vaccine (2007) 0.90
Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains. Infect Immun (2004) 0.89
A method for isolating Trypanosoma cruzi amastigotes from spleen and liver using two-step discontinuous gradient centrifugation. J Parasitol (1983) 0.88
Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology (2001) 0.87
Comparative study of bone marrow and blood B cells in infantile and acquired agammaglobulinemia. Possible role of circulating anti-IgM in pathogenesis. J Clin Invest (1973) 0.84
Immunization with Ascaris suum extract impairs T cell functions in mice. Cell Immunol (1995) 0.84
Capture enzyme-linked immunosorbent assay to detect specific immunoglobulin E in sera of patients with paracoccidioidomycosis. Am J Trop Med Hyg (2001) 0.82
Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice. Mem Inst Oswaldo Cruz (1992) 0.82
Leishmania braziliensis amastigotes stimulate production of IL-1β, IL-6, IL-10 and TGF-β by peripheral blood mononuclear cells from nonendemic area healthy residents. Parasite Immunol (2014) 0.80
Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes. Parasitology (2007) 0.79
Trypanosoma cruzi amastigotes: development in vitro and infectivity in vivo of the forms isolated from spleen and liver. Acta Trop (1985) 0.79
Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen. Immunology (1996) 0.78
Immunomodulation induced by Ascaris suum extract in mice: effect of anti-interleukin-4 and anti-interleukin-10 antibodies. Scand J Immunol (1998) 0.78
IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen. Immunol Lett (1997) 0.77
Modulation of delayed-type hypersensitivity during the time course of immune response to a protein antigen. Immunology (2001) 0.77
Susceptibility and resistance to Leishmania amazonensis in H-2q syngeneic high and low antibody responder mice (Biozzi mice). Scand J Immunol (1998) 0.77
Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi. Immunology (1999) 0.76
The influence of lymphatic drainage in experimental Trypanosoma cruzi infection. Acta Trop (1984) 0.76
Specific cutaneous hypersensitivity responses in mice infected or immunized with Trypanosoma cruzi. Parasite Immunol (1983) 0.75
Pattern of cytokine secretion by peripheral blood cells of patients with multiple sclerosis in Brazil. Mult Scler (2000) 0.75
[Serological survey on the prevalence of anti-HTLV-III antibodies in a psychiatric hospital]. Rev Paul Med (1987) 0.75
Activation of CD4+ and CD8+ parasite -specific T-cells by macrophages infected with live T. cruzi amastigotes. Immunol Lett (1998) 0.75
[Serological survey of the prevalence of anti-HIV antibodies in prisoners of the public prison of Sorocaba]. Rev Paul Med (1988) 0.75
Trypanosoma cruzi: studies on the reactivity of antibodies bound to the surface of blood forms at the early phase of infection. Acta Trop (1994) 0.75
Contact hypersensitivity to DNFB in Trypanosoma cruzi infected mice. Rev Inst Med Trop Sao Paulo (1982) 0.75
Enumeration of Trypanosoma cruzi-specific antibody-secreting cells by solid-phase immunoenzymatic technique. J Immunol Methods (1987) 0.75
Specific suppression of delayed hypersensitivity expression to Trypanosoma cruzi in mice. Parasite Immunol (1986) 0.75